Lee Gary K. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$2,784.88

Insider Activity of Lee Gary K.

According to the SEC Form 4 filings, Lee Gary K., being in a position of

  1. Chief Scientific Officer at Lyell Immunopharma, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 3674 shares for $71,693,
    over all time since 2025-08-11, has bought 0 shares, and sold 5394 shares for $89,799.

Biography of Lee Gary K.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $71,6936100

Comparison of Insiders on Amount of Buys and Sells

2026-08-21SaleLyell Immunopharma, Inc.
LYEL
Chief Scientific Officer
1,457
0.0062%
$15.54$22,642-30.65%
2026-08-10SaleLyell Immunopharma, Inc.
LYEL
Chief Scientific Officer
131
0.0006%
$14.34$1,879-23.8%
2026-05-11SaleLyell Immunopharma, Inc.
LYEL
Chief Scientific Officer
130
0.0005%
$18.92$2,460-32.4%
2026-02-11SaleLyell Immunopharma, Inc.
LYEL
Chief Scientific Officer
1,671
0.0076%
$23.39$39,085-40.3%
2026-02-10SaleLyell Immunopharma, Inc.
LYEL
Chief Scientific Officer
147
0.0007%
$23.12$3,399-38.55%
2025-11-10SaleLyell Immunopharma, Inc.
LYEL
Chief Scientific Officer
138
0.0007%
$16.16$2,230-1.33%
2025-08-21SaleLyell Immunopharma, Inc.
LYEL
Chief Scientific Officer
1,453
0.0075%
$10.54$15,320+67.89%
2025-08-12SaleLyell Immunopharma, Inc.
LYEL
Chief Scientific Officer
136
0.0009%
$10.34$1,406+69.16%
2025-08-11SaleLyell Immunopharma, Inc.
LYEL
Chief Scientific Officer
131
0.0008%
$10.53$1,379+69%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.